RT Journal Article
SR Electronic
T1 Central Nervous System Manifestations in COVID-19 Patients: A Systematic Review and Meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.21.20158691
DO 10.1101/2020.07.21.20158691
A1 Nazari, Shahrzad
A1 Jafari, Amirhossein Azari
A1 Mirmoeeni, Seyyedmohammadsadeq
A1 Sadeghian, Saeid
A1 Heidari, Mohammad Eghbal
A1 Sadeghian, Siavash
A1 Asarzadegan, Farhad
A1 Puormand, Seyed Mahmoud
A1 Alikhani, Katayoun
A1 Ebadi, Hamid
A1 Fathi, Davood
A1 Dalvand, Sahar
YR 2020
UL http://medrxiv.org/content/early/2020/07/22/2020.07.21.20158691.abstract
AB Background At the end of December 2019, a novel respiratory infection, initially reported in China, known as COVID-19 initially reported in China, and later known as COVID-19, led to a global pandemic. Despite many studies reporting respiratory infections as the primary manifestations of this illness, an increasing number of investigations have focused on the central nervous system (CNS) manifestations in COVID-19. In this study, we aimed to evaluate the CNS presentations in COVID-19 patients in an attempt to identify the common CNS features and provide a better overview to tackle this new pandemic.Methods In this systematic review and meta-analysis, we searched PubMed, Web of Science, Ovid, Embase, Scopus, and Google Scholar. Included studies were publications that reported the CNS features between January 1st, 2020, to April 20th, 2020. The data of selected studies were screened and extracted independently by four reviewers. Extracted data analyzed by using STATA statistical software. The study protocol registered with PROSPERO (CRD42020184456).Results Of 2353 retrieved studies, we selected 64 studies with 11282 patients after screening. Most of the studies were conducted in China (58 studies). The most common CNS symptom of COVID-19 were Headache (8.69%, 95%CI: 6.76%-10.82%), Dizziness (5.94%, 95%CI: 3.66%-8.22%), and Impaired consciousness (1.9%, 95%CI: 1%-2.79%).Conclusions The growing number of studies have reported COVID-19, CNS presentations as remarkable manifestations that happen. Hence, understanding the CNS characteristics of COVID-19 can help us for better diagnosis and ultimately prevention of worse outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:our research is not a critical oversight functions on human subjects. it is a systematic review and meta-analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the related data is available in the manuscript.CNSCentral nervous systemCOVID-19Coronavirus disease 2019SARS-CoV-2Severe acute respiratory syndrome coronavirus 2PHEICPublic health emergency of international concernWHOWorld health organizationPRISMAPreferred reporting items for systematic reviews and meta-analysesPNSPeripheral nervous systemBBBBlood brain barrierACE2Angiotensin-converting enzyme 2CIConfidence interval